Table of Contents Table of Contents
Previous Page  34 / 194 Next Page
Information
Show Menu
Previous Page 34 / 194 Next Page
Page Background

Sensitivity analysis

:

• AMDL = 50,000 copies/mL target region of

Variola virus

• ≥ 500 bp must receive permission from WHO

i

ti

i t

th

O th i

i

hibit d

Variola Working Group SMPR:

Tailor Panel to Assay Based on Bioinformatics

• nser on n o ano er

r opoxv rus

s pro e

Establish Probability of Detection at AMDL w/in collection buffer (≥ 95%)

Establish Probability of Detection at AMDL w/in aerosol environmental

matrix (≥ 95%)

• Inclusivity panel –

Variola virus

: ≥ 2 strain target regions

• at least one from each primary clade

(

Li, et. al. PNAS (2007) Oct. 2;104(40):15787-15792.)

• encompass differences in target region

• Based on bioinformatic analysis

Ensure all inclusivity strains are detected at 2X AMDL in collection buffer

Ensure all inclusivity strains are detected at 2X AMDL in environmental

matrix

Ensure target is detected at 2X AMDL w/in pool of environmental panel

organisms (pools of up to 10 organisms at 10X AMDL for each)

Specificity analysis:

• Exclusivity panel – near neighbor (

Orthopoxvirus

):

• All poxvirus strains listed in the table (one from each major clade)

• See AOAC Website for the most updated list

Variola Working Group SMPR:

Tailor Panel to Assay Based on Bioinformatics

Species

Strain

Commercial availability

Vaccinia

Elsree

ATCC VR‐1549

Cowpox

Brighton

ATCC VR‐302

Ectromelia

Moscow

ATCC VR‐1374

Monkeypox

V79‐I‐005

BEI NR‐2324

Monkeypox

USA‐2003

BEI NR‐2500

Raccoonpox

Herman

ATCC VR‐838

Skunkpox

ATCC

l

• Any additional strains with greater similarity to the assay’s target region(s)

than the strains listed above in the table

• Based on bioinformatic analysis

Ensure all exclusivity strains are NOT detected at 10X AMDL in collection buffer

Vo epox

ATCC

Camelpox

BEI

Taterapox

BEI

Parapoxvirus Orf

Vaccine

Colorado Serum Company